| ATRY Stock | | | EUR 3.20 0.08 2.44% |
Director
Mr. Victor Gonzalez Rumayor serves as RD Director of Atrys Health, S.A. He was founder and Technical Director of Super Seed Biotech, one of the first Spanish biotechnology spinoff. He was Professor of Physiology and Biotechnology at the University of Segovia and Director of the Innovation Circle of Biotechnology in Madrid. He was Senior Researcher in Regenerative Medicine and Advanced Therapies at Health Institute Carlos III, Director of Programs at the Direccin General de Terapias Avanzadas y Trasplantes in the Health Ministry and Advisor at the Ministry of Health. Government representative at the Policy and Coordinating Committee for Human Reproductive Health and Research .
| Phone | 34 91 781 94 65 |
| Web | https://www.atryshealth.com |
Atrys Health Management Efficiency
Atrys Health's management efficiency ratios could be used to measure how well Atrys Health manages its routine affairs as well as how well it operates its assets and liabilities.
Atrys Health SL has accumulated 146.81
M in total debt with debt to equity ratio
(D/E) of 0.95, which is about average as compared to similar companies. Atrys Health SL has a current ratio of 1.71, which is within standard range for the sector. Debt can assist Atrys Health until it has trouble settling it off, either with new capital or with free cash flow. So, Atrys Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Atrys Health SL sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Atrys to invest in growth at high rates of return. When we think about Atrys Health's use of debt, we should always consider it together with cash and equity.
Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain. ATRYS HEALTH operates under Biotechnology classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 525 people. Atrys Health SL (ATRY) is traded on Madrid Exchange in Spain and employs 2,397 people.
Management Performance
Atrys Health SL Leadership Team
Elected by the shareholders, the Atrys Health's board of directors comprises two types of representatives: Atrys Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Atrys. The board's role is to monitor Atrys Health's management team and ensure that shareholders' interests are well served. Atrys Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Atrys Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Santiago Sanahuja, Executive Chairman of the Board | |
| Helena VidalFolch, Head Communication | |
| Gabriela Camunas, G Counsel | |
| Carlos CordonCardo, Scientific Vice President | |
| Anna Valero, Diagnostics Director | |
| Encarna Vega, Adm Director | |
| Maria Marin, Head Relations | |
| Isabel Fernandez, Chief Executive Officer | |
| Carlo Greco, Vice President of Medical Radiotherapy | |
| Victor Rumayor, R&D Director | |
| Jose Ginesta, Chief Financial Officer | |
| Zvi Fuchs, Founder VP | |
| Eduardo Dussel, Director of Teleradiology | |
| Carlos Girn, Chief Officer | |
Atrys Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Atrys Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in Atrys Stock
Atrys Health financial ratios help investors to determine whether Atrys Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Atrys with respect to the benefits of owning Atrys Health security.